Cutting-Edge Research adds to medical knowledge and will change medical practice and promising radical cure to diarrhea sufferers, throughout Bacterial Fecal Microbial Culture Transplantation.(BMFCT).

Research Scientists at one of the ND Pharma & Biotech´s associated clinic and Hospital in Chicago, USA, has conducted and summarize the protocol for Bacterial Fecal Transplantation from healthy donors of fecal bacteria, within an extensive program of research about new groundbreaking medical clinical strategies and therapies against diarrhea, chronic, sub-chronic, acute and sub-acute, especially those caused by Clostridium Difficile class-like bacterias. A number of pilot transplantations were made with a cure rate of 98% of monitored patients, most of them volunteers, that reported a complete satisfaction after the procedure and the emotion of recovery of a healthy and disease-free life.

ND Pharma & Biotech associated scientists are members of an extensive Biotechnology program co-funded by the National Institutes of Health that are researching and identified the gene sequences and other relevant data about the number of bacterias living within human organism and their implications in human health and disease. This scientific team, has co-participated in the Human Oral Microbiome Project, that has created and classified an extensive Microbiome Library of more than 300 species living within human oral cavity, with their complete sequencing processes.

The average American gets diarrhea at least once a year – more for some people with chronic bowel conditions such as Irritable Bowel Disease (IBD) or Irritable Bowel Syndrome (IBS), who can suffer it on a daily basis. Hundreds of different microbes, ranging from parasites to bacteria to viruses, can cause these uncomfortable bouts of runny, watery stool. One such popular bacteria is called Clostridium Difficile, or C. diff for short. This nasty spore-like bacteria naturally lives in your colon. However, an overgrowth of C. diff leads to chronic, liquid stool and painful stomach cramps that must be treated by antibiotics to kill it off. That was, at least, until the 21st century. During a fecal transplant procedure, stool is collected from the intestine of a healthy person and transplanted into the intestine of someone suffering from a chronic disease, such as C. diff or irritable bowel syndrome. 

The premise of fecal transplants lies with the fact that healthy adults have specific microbes in their colon that ill people do not possess. Their colons are filled with "good bacteria" that can help put a stop to the unhealthy bacteria that are wreaking havoc on your body. Scientists state that the diarrhea, nausea, and stomach pains associated with these illnesses may actually be nothing more than a bacterial overgrowth – of the bad kind.  Taking stool from a healthy adult, promote growing and transplanting it into the intestines of someone who suffers a chronic disease or infection – such as irritable bowel disease or recurrent Clostridium Difficile infections – can help stop recurrent flare ups and stop the clostridium bacteria in its tracks.

ND Pharma & Biotech has made a commitment to give more hope to the life of today and tomorrow. Bringing ingredients, active principles and novel molecules to the “Big Pharma” industry and sharing with most of them, (our clients) such commitment, to let themselves to create, manufacture,  and deliver the most advanced solutions to worldwide patients and let them to treat and fight against their aggressive conditions and diseases, specifically in the case of cancer. (Oncology).

We help them to create really innovative solutions that will make the difference, improving genuinely their lives and the life of affected people. To get these things possible we are embraced in a number of high-profile / top-class investigations and research, focusing on the discovery of novel molecules and therapies designed and engineered for unmet medical and health demands and conditions, including but not limited to certain types of cancer and oncological diseases as solid tumors, like pancreatic cancer, breast cancer and advanced renal cell carcinoma, as well as other haematological-oncological conditions.

But our mission, do not appear only when the disease is onset and clinically evolved. We are going further back to the point of participate throughout our Food & Nutrition Division, on the most extensive detoxification programs and products (broad consumption), till the point of making possible our vision of “removal the chemical – toxic elements and cellular waste deposits present within our body, and coming up from the food and alimentary chain, mean, ingested within foods. In this effort we are praying to get every producer, processor or seller involved with this ideal, that are for us the true reason for living and doing what we do, and every other effort that we should have to do,. By such means we are promoting and cultivating the meaningful spirit of making life better, just making things much better than any others are doing it now. That is the hope for tomorrow that challenges us.

www.ndpharmabiotech.com

Great acceptance is showing the M.A.R.S. (Micro Alcohol Reaction System), another ND Pharma & Biotech Innovation that is showing great acceptance within the producers, processors and bottlers of the beer sector. From its inception to the different approaches and test performed, every other result has confirmed the impact on quality and taste perception of beer-processed with M.A.R.S. against same brands without it. Zero impact on flavor, but a better mouthfeel, and the amazing effect within the body, without practically hangover sensation even in double or triple consumption rate, is making the difference respect to any other processing system and technology. The actual objective now for the company is to reach the Top 10 Beer Companies worldwide, since some of them are now active clients adapting system and technology to their elaborated brands and products.